Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

BICO Group AB

Start price
Target price
Perf. (%)
€3.13
03.09.22
-
03.09.23
171.89%
14.11.22

Could be worthwhile Investment >10% per year
buy
Rio Tinto plc

Start price
Target price
Perf. (%)
€54.40
06.07.22
-
06.07.23
15.94%
14.11.22

buy
Sylvania Platinum Ltd

Start price
Target price
Perf. (%)
€0.95
06.07.22
-
06.07.23
13.68%
14.11.22

buy
Agco Corp.

Start price
Target price
Perf. (%)
€95.25
30.06.22
-
30.06.23
31.03%
14.11.22

buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€217.05
29.03.22
-
29.03.23
-7.39%
14.11.22

buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.35
13.11.21
€2.00
13.11.22
-47.91%
14.11.22

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
buy
ALK-Abelló A/S B

Start price
Target price
Perf. (%)
€22.33
13.11.21
€24.00
13.11.22
-37.17%
14.11.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€22.26
13.11.21
€28.00
13.11.22
-88.09%
14.11.22

Higher risks for its business
buy
Intershop Communications AG

Start price
Target price
Perf. (%)
€4.68
13.11.21
€5.00
13.11.22
-36.54%
14.11.22

Could be worthwhile Investment >10% per year
Known brand
Top 10 in its market
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€13.55
13.11.21
-
13.11.22
-69.88%
14.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€7.37
13.11.21
-
13.11.22
-79.10%
14.11.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Innovative
Top 10 in its market
buy
Siemens AG

Start price
Target price
Perf. (%)
€113.80
12.06.22
€105.00
01.02.23
8.08%
13.11.22

buy
Nel ASA

Start price
Target price
Perf. (%)
€1.60
25.08.22
€2.00
25.08.23
-17.94%
13.11.22

Future proof or reliable business model
Innovative
Valuable balance sheet
ROE higher than 10% per year
Nel ASA

Start price
Target price
Perf. (%)
€2.04
15.11.21
€1.00
15.11.22
-35.60%
13.11.22

Revenue growth > 30% per year expected
Small challenges to pay loans and raise capital
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Argan

Start price
Target price
Perf. (%)
€112.20
12.11.21
€118.00
12.11.22
-27.90%
13.11.22

Could be worthwhile Investment >10% per year
buy
adidas AG

Start price
Target price
Perf. (%)
€280.80
12.11.21
€300.00
12.11.22
-51.40%
13.11.22

Could be worthwhile Investment >10% per year
buy
STMicroelectronics N.V.

Start price
Target price
Perf. (%)
€44.81
12.11.21
-
12.11.22
-18.80%
13.11.22

Could be worthwhile Investment >10% per year
buy
Munic Sa

Start price
Target price
Perf. (%)
€3.11
12.11.21
€3.80
12.11.22
-2.57%
13.11.22

Could be worthwhile Investment >10% per year
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.71
16.08.22
€5.00
16.08.23
-14.13%
12.11.22

Could be worthwhile Investment >10% per year
buy
AMTD IDEA Group ADR

Start price
Target price
Perf. (%)
€2.10
30.10.22
-
30.10.23
-3.81%
12.11.22

Could be very worthwhile Investment >20% year
buy
TCR2 Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.56
30.10.22
-
30.10.23
-16.12%
12.11.22

Risky Investment
buy
Tilray Inc

Start price
Target price
Perf. (%)
€3.87
07.11.22
€4.00
07.11.23
4.96%
12.11.22

Innovative
Growths faster than the competition
Well known brand
Very small cyclical dependencies
buy
Varta AG

Start price
Target price
Perf. (%)
€77.86
04.08.22
€38.00
04.08.23
-56.54%
12.11.22

Very positive Cash Flow expected
High Investments for future growth
Some uniques
Undervalued
buy
Swedish Orphan Biovitrum Ab

Start price
Target price
Perf. (%)
€23.37
11.11.21
€28.00
11.11.22
-18.19%
12.11.22

Could be worthwhile Investment >10% per year